Healthcare IT News December 13, 2024
A health analytics company is partnering with pharma to allow patients to unify their health information across multiple providers. Using artificial intelligence, the platform analyzes medical records and makes recommendations.
Unite Genomics, a Mark Cuban portfolio company, announced a new partnership this week that the company says can help personalize and tailor patient care insights based on their medical records and spot potential gaps in care. The company said Monday that its direct-to-consumer platform uses artificial intelligence to analyze the medical care patients may have received and alert them to missing tests or treatment options.
Already in use for ALS, certain cancers and other rare diseases, the technology – enabled by healthcare interoperability requirements on providers – presents a...
Today's Sponsors
Today's Sponsor